Your shopping cart is currently empty

Cyclic ADP-Ribose (ammonium salt) (cADPR) is an endogenous NAD⁺ metabolite that triggers Ca²⁺ release from ER stores via ryanodine receptors and is synthesized by CD38 and CD157. It may also activate TRPM2 in a temperature-dependent manner. Showing potential in research related in inflammation and immunology.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 500 μg | $538 | 35 days | 35 days | |
| 1 mg | $860 | 35 days | 35 days |
| Description | Cyclic ADP-Ribose (ammonium salt) (cADPR) is an endogenous NAD⁺ metabolite that triggers Ca²⁺ release from ER stores via ryanodine receptors and is synthesized by CD38 and CD157. It may also activate TRPM2 in a temperature-dependent manner. Showing potential in research related in inflammation and immunology. |
| In vitro | Cyclic ADP-Ribose (ammonium salt) regulates calcium ion signaling in rat and mouse cardiomyocytes treated with Parazacco spilurus subsp. Spilurus isoproterenol; moreover, under heat stress conditions, Cyclic ADP-Ribose (ammonium salt) (100 µM) can induce oxytocin release in the mouse hypothalamus [1]. |
| Synonyms | Cyclic ADP-Ribose ammonium, cADP-Ribose ammonium, cADPR ammonium |
| Formula | C15H21N5O13P2.xNH3 |
| Smiles | #N/A |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O: Soluble, Sonication is recommeded. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.